RACHELLE DOODY

Concepts (472)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Alzheimer Disease
151
2025
766
22.260
Why?
Antibodies, Monoclonal, Humanized
21
2025
490
6.770
Why?
Indans
29
2017
53
4.580
Why?
Cholinesterase Inhibitors
29
2017
90
4.490
Why?
Piperidines
29
2017
198
4.220
Why?
Cognition Disorders
28
2016
555
4.220
Why?
Amyloid beta-Peptides
21
2025
206
4.100
Why?
Neuropsychological Tests
56
2021
924
3.340
Why?
Cognition
30
2022
736
3.040
Why?
Activities of Daily Living
24
2021
405
2.950
Why?
Nootropic Agents
18
2017
25
2.690
Why?
Dementia
27
2016
448
2.410
Why?
Aged, 80 and over
78
2025
6372
2.240
Why?
Aged
134
2025
19098
2.140
Why?
Clinical Trials as Topic
24
2024
1088
2.130
Why?
Cognitive Dysfunction
7
2023
225
2.090
Why?
Double-Blind Method
33
2025
1590
1.930
Why?
Memantine
9
2012
17
1.830
Why?
Psychiatric Status Rating Scales
25
2016
797
1.700
Why?
Disease Progression
31
2024
2025
1.690
Why?
Drug Approval
2
2023
40
1.540
Why?
Mental Status and Dementia Tests
6
2023
17
1.330
Why?
Excitatory Amino Acid Antagonists
6
2016
96
1.320
Why?
Brain
18
2025
2964
1.310
Why?
Severity of Illness Index
30
2021
2839
1.260
Why?
Humans
188
2025
123223
1.230
Why?
Male
121
2025
60117
1.210
Why?
Middle Aged
84
2025
26016
1.180
Why?
Psychometrics
14
2021
657
1.160
Why?
Female
123
2025
65549
1.130
Why?
Plaque, Amyloid
4
2022
63
1.080
Why?
Feasibility Studies
2
2024
753
1.020
Why?
Amnesia
4
2011
20
1.010
Why?
Patient Care
2
2021
100
0.990
Why?
Apolipoproteins E
9
2014
190
0.960
Why?
United States Food and Drug Administration
4
2023
148
0.920
Why?
Amyloid Precursor Protein Secretases
2
2013
62
0.860
Why?
Azepines
2
2013
61
0.850
Why?
Treatment Outcome
35
2024
12141
0.850
Why?
Alanine
2
2013
181
0.840
Why?
Amyloidosis
1
2022
65
0.780
Why?
Mental Status Schedule
14
2016
44
0.730
Why?
Antiparkinson Agents
4
2024
65
0.720
Why?
Positron-Emission Tomography
8
2024
288
0.680
Why?
Research
2
2021
263
0.670
Why?
Medical Futility
1
2020
36
0.670
Why?
Pseudobulbar Palsy
2
2016
4
0.650
Why?
Quinidine
2
2016
9
0.650
Why?
Dextromethorphan
2
2016
11
0.650
Why?
Geriatric Assessment
9
2012
169
0.630
Why?
Longitudinal Studies
9
2017
1309
0.620
Why?
Biomarkers
22
2022
2946
0.600
Why?
Indoles
2
2009
180
0.590
Why?
Parkinson Disease
4
2024
671
0.560
Why?
Magnetic Resonance Imaging
10
2025
3546
0.540
Why?
Drug Discovery
3
2017
170
0.540
Why?
Mental Recall
2
2015
142
0.540
Why?
Markov Chains
1
2016
83
0.500
Why?
Models, Statistical
4
2018
475
0.480
Why?
tau Proteins
8
2022
189
0.470
Why?
Randomized Controlled Trials as Topic
8
2013
1068
0.470
Why?
Oligonucleotides
2
2024
88
0.440
Why?
Intelligence Tests
4
2012
57
0.420
Why?
Vitamin E
6
2010
64
0.420
Why?
Attention
6
2012
197
0.420
Why?
Language
9
2016
202
0.420
Why?
Huntington Disease
2
2024
141
0.410
Why?
Drug Therapy, Combination
4
2012
1151
0.410
Why?
Regression Analysis
4
2013
771
0.400
Why?
Functional Laterality
6
1999
181
0.400
Why?
International Cooperation
7
2022
160
0.400
Why?
Early Diagnosis
5
2018
178
0.380
Why?
Interview, Psychological
1
2012
97
0.380
Why?
Reproducibility of Results
13
2021
2830
0.360
Why?
Patient Dropouts
2
2016
52
0.360
Why?
Advisory Committees
6
2024
148
0.350
Why?
Caregivers
8
2024
572
0.340
Why?
Health Policy
2
2009
213
0.340
Why?
Apolipoprotein E4
8
2016
43
0.340
Why?
Attitude to Health
2
2009
259
0.340
Why?
Multicenter Studies as Topic
4
2016
263
0.330
Why?
Memory
8
2012
361
0.320
Why?
Patient Compliance
2
2009
467
0.310
Why?
Basal Ganglia Diseases
4
2000
27
0.310
Why?
United States
16
2023
10637
0.310
Why?
Evidence-Based Medicine
1
2012
622
0.310
Why?
Adult
20
2024
29072
0.310
Why?
Trust
1
2009
75
0.300
Why?
Patient Selection
3
2013
685
0.300
Why?
Algorithms
7
2016
1593
0.300
Why?
Research Design
4
2021
685
0.300
Why?
Clinical Trials, Phase III as Topic
3
2018
68
0.290
Why?
Insulin
1
2013
1200
0.290
Why?
Polymorphism, Genetic
1
2011
809
0.290
Why?
Amyloidogenic Proteins
3
2022
6
0.290
Why?
Academic Medical Centers
1
2009
299
0.280
Why?
Depression
4
2012
1217
0.280
Why?
Drug Industry
4
2017
46
0.260
Why?
Tomography, Emission-Computed, Single-Photon
2
1997
105
0.260
Why?
Informed Consent
1
2009
341
0.260
Why?
Asymptomatic Diseases
2
2022
78
0.250
Why?
Dementia, Vascular
3
2015
16
0.250
Why?
Supranuclear Palsy, Progressive
2
2016
29
0.250
Why?
alpha-Synuclein
2
2024
114
0.240
Why?
Treatment Failure
4
2014
338
0.240
Why?
Primary Health Care
1
2011
753
0.230
Why?
Cohort Studies
14
2022
4710
0.230
Why?
Models, Psychological
2
2010
136
0.230
Why?
Phenylcarbamates
2
2006
15
0.230
Why?
Psychotic Disorders
2
1995
140
0.230
Why?
Observer Variation
5
2011
296
0.220
Why?
Injections, Subcutaneous
1
2024
126
0.220
Why?
Likelihood Functions
3
2012
112
0.220
Why?
Nerve Degeneration
2
1996
126
0.220
Why?
Aphasia
2
1993
14
0.210
Why?
Medical History Taking
1
2003
106
0.210
Why?
Biomedical Research
1
2009
518
0.210
Why?
China
3
2021
240
0.210
Why?
Age of Onset
6
2014
581
0.210
Why?
Geriatrics
1
2003
72
0.210
Why?
Cerebrovascular Circulation
2
1997
434
0.210
Why?
Dose-Response Relationship, Drug
5
2021
1682
0.210
Why?
Prospective Studies
8
2021
6040
0.210
Why?
Antibodies, Monoclonal
3
2023
1009
0.210
Why?
Alleles
2
2005
1603
0.200
Why?
Practice Patterns, Physicians'
1
2008
713
0.200
Why?
Case-Control Studies
10
2019
3249
0.200
Why?
Computer Communication Networks
1
2022
15
0.200
Why?
Education
4
2009
105
0.200
Why?
Adaptor Proteins, Signal Transducing
2
2017
530
0.200
Why?
Data Interpretation, Statistical
2
2016
229
0.190
Why?
Time Factors
7
2017
6221
0.190
Why?
Tacrine
1
2001
2
0.190
Why?
Visual Perception
2
2004
125
0.190
Why?
Proportional Hazards Models
5
2016
1306
0.190
Why?
Lipids
3
2019
515
0.190
Why?
Risk Factors
10
2020
10015
0.190
Why?
Factor Analysis, Statistical
3
2012
226
0.190
Why?
Self-Assessment
3
2006
66
0.180
Why?
Genetic Predisposition to Disease
6
2019
3084
0.180
Why?
Diarrhea
2
2015
316
0.180
Why?
Psychomotor Performance
3
2012
188
0.180
Why?
Genotype
7
2017
2542
0.180
Why?
Sensitivity and Specificity
7
2011
2026
0.180
Why?
Clinical Trials, Phase II as Topic
2
2018
71
0.170
Why?
Cross-Sectional Studies
5
2015
3378
0.170
Why?
Prevalence
5
2016
2406
0.170
Why?
Motor Activity
3
2004
522
0.170
Why?
Analysis of Variance
3
2011
1008
0.170
Why?
Extremities
1
2000
82
0.160
Why?
Social Behavior
3
2012
207
0.160
Why?
Awareness
4
2005
81
0.160
Why?
DNA Copy Number Variations
3
2014
941
0.160
Why?
Microglia
2
2017
96
0.160
Why?
Heptanoic Acids
2
2010
77
0.160
Why?
Diagnosis, Differential
5
2011
1877
0.150
Why?
Thiadiazines
1
2018
1
0.150
Why?
Cyclic S-Oxides
1
2018
2
0.150
Why?
Drug Combinations
2
2016
270
0.150
Why?
Mental Processes
3
2009
41
0.150
Why?
Immunity
1
2019
181
0.150
Why?
Aggression
2
2010
226
0.150
Why?
Phospholipase C gamma
1
2017
17
0.140
Why?
Pyrroles
2
2010
177
0.140
Why?
Verbal Behavior
1
1997
52
0.140
Why?
Elder Abuse
2
2008
24
0.140
Why?
Predictive Value of Tests
6
2017
2112
0.140
Why?
Genetic Loci
1
2019
333
0.140
Why?
Lewy Body Disease
2
2015
18
0.140
Why?
Blood Pressure
1
2003
1325
0.140
Why?
Pyrrolidinones
1
2017
17
0.140
Why?
Movement Disorders
1
2000
221
0.140
Why?
Cerebral Cortex
2
2000
448
0.140
Why?
Receptors, Immunologic
1
2017
110
0.140
Why?
Statistics as Topic
2
2016
250
0.140
Why?
Acetamides
1
2017
49
0.130
Why?
Data Accuracy
1
2016
25
0.130
Why?
Self Concept
3
2005
157
0.130
Why?
Health Services Accessibility
1
2021
594
0.130
Why?
Frontotemporal Dementia
1
2015
40
0.120
Why?
Nervous System
1
1996
128
0.120
Why?
Antipsychotic Agents
2
2017
375
0.120
Why?
Membrane Glycoproteins
1
2017
413
0.120
Why?
Headache
1
2015
108
0.120
Why?
Judgment
2
2012
34
0.120
Why?
Patient Outcome Assessment
1
2015
94
0.120
Why?
Immunity, Innate
1
2017
372
0.120
Why?
Follow-Up Studies
5
2017
5049
0.110
Why?
Intention to Treat Analysis
1
2014
56
0.110
Why?
Korea
2
2011
35
0.110
Why?
Gene Dosage
2
2013
441
0.110
Why?
Oligopeptides
1
2014
118
0.110
Why?
alpha7 Nicotinic Acetylcholine Receptor
1
2014
57
0.110
Why?
Interpersonal Relations
1
2015
225
0.110
Why?
Spasm
2
2009
48
0.110
Why?
Placebos
3
2021
238
0.110
Why?
Endpoint Determination
2
2013
53
0.110
Why?
Receptors, Complement 3b
1
2013
8
0.110
Why?
Apathy
1
2012
9
0.110
Why?
Mental Health
1
1996
346
0.100
Why?
Neuropsychology
1
2013
23
0.100
Why?
Dopamine Agents
1
2012
28
0.100
Why?
Polymorphism, Single Nucleotide
3
2017
2586
0.100
Why?
Brain Damage, Chronic
1
1992
30
0.100
Why?
Aging
4
2011
1173
0.100
Why?
Dominance, Cerebral
1
1992
54
0.100
Why?
Cerebral Infarction
1
1992
46
0.100
Why?
Fetal Hypoxia
1
2012
13
0.100
Why?
Antioxidants
3
2009
338
0.100
Why?
Binomial Distribution
1
2012
3
0.100
Why?
Cyclic AMP Response Element-Binding Protein
1
2012
110
0.100
Why?
Genome-Wide Association Study
3
2019
1642
0.100
Why?
Biostatistics
1
2012
10
0.100
Why?
Hobbies
1
2012
4
0.100
Why?
Databases, Bibliographic
1
2012
20
0.100
Why?
Cardiovascular Diseases
1
2004
1863
0.100
Why?
Phosphoric Diester Hydrolases
1
2012
62
0.100
Why?
Neurologic Examination
1
1992
195
0.100
Why?
Executive Function
1
2012
106
0.100
Why?
Memory Disorders
2
2012
235
0.100
Why?
Linear Models
4
2013
669
0.100
Why?
Diagnostic Imaging
3
2012
271
0.100
Why?
Orientation
1
2012
50
0.100
Why?
Hand
1
1992
102
0.100
Why?
Movement
2
2008
167
0.100
Why?
Problem Solving
1
2012
64
0.100
Why?
Serum
1
2011
46
0.100
Why?
Disabled Persons
1
2013
99
0.100
Why?
Social Adjustment
1
2012
85
0.100
Why?
Amyloid beta-Protein Precursor
1
2012
121
0.100
Why?
Bias
1
2012
125
0.090
Why?
Urinary Tract Infections
1
2015
293
0.090
Why?
Meta-Analysis as Topic
1
2012
153
0.090
Why?
Plasma
1
2011
96
0.090
Why?
Lithium Chloride
1
2011
8
0.090
Why?
Sphingomyelins
1
2011
16
0.090
Why?
Diabetes Mellitus
2
2013
849
0.090
Why?
Palate, Soft
1
1990
16
0.090
Why?
Diagnostic Techniques and Procedures
1
2011
29
0.090
Why?
Voice Disorders
1
1990
18
0.090
Why?
Bayes Theorem
1
2012
278
0.090
Why?
Intelligence
2
2013
98
0.090
Why?
Myoclonus
1
1990
32
0.090
Why?
Texas
5
2011
3560
0.090
Why?
Publishing
1
2011
108
0.090
Why?
Retrospective Studies
4
2023
16033
0.090
Why?
Sex Factors
2
2004
1260
0.090
Why?
Blood Proteins
1
2010
116
0.090
Why?
Quality of Health Care
2
2006
391
0.080
Why?
Tumor Suppressor Proteins
1
2013
467
0.080
Why?
Congresses as Topic
1
2011
170
0.080
Why?
Hippocampus
3
2017
820
0.080
Why?
Psychomotor Agitation
1
2010
56
0.080
Why?
Histamine Antagonists
1
2009
17
0.080
Why?
Weight Loss
1
2013
478
0.080
Why?
Nausea
1
2009
97
0.080
Why?
Government Agencies
1
2009
11
0.080
Why?
Cross-Cultural Comparison
3
1998
60
0.080
Why?
Health Services Administration
1
2009
11
0.080
Why?
Drug and Narcotic Control
1
2009
18
0.080
Why?
Survival
2
2006
19
0.080
Why?
National Health Programs
1
2009
19
0.080
Why?
Computer Simulation
1
2012
635
0.080
Why?
Public Policy
1
2009
51
0.080
Why?
Russia
1
2008
39
0.080
Why?
Professional-Patient Relations
1
2009
85
0.080
Why?
Sleep Initiation and Maintenance Disorders
1
2009
94
0.080
Why?
Europe
2
2010
374
0.070
Why?
Databases, Factual
3
2011
1168
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
1292
0.070
Why?
Educational Status
2
2011
270
0.070
Why?
Motor Skills
1
2008
85
0.070
Why?
Reaction Time
2
2005
172
0.070
Why?
Galantamine
2
2006
10
0.070
Why?
Cost of Illness
2
2010
242
0.070
Why?
Rivastigmine
2
2006
17
0.070
Why?
Primary Prevention
2
2006
164
0.070
Why?
Proxy
1
2006
15
0.070
Why?
Technetium Tc 99m Exametazime
2
1997
8
0.070
Why?
Organotechnetium Compounds
2
1997
12
0.070
Why?
Speech
2
2000
57
0.070
Why?
Nuclear Proteins
1
2013
1265
0.070
Why?
Pilot Projects
2
2008
1388
0.070
Why?
Skin Neoplasms
1
2013
796
0.070
Why?
Oximes
2
1997
48
0.070
Why?
Chi-Square Distribution
1
2007
586
0.070
Why?
Central Nervous System Agents
1
2006
15
0.060
Why?
Mass Screening
1
2011
788
0.060
Why?
Delusions
2
1995
17
0.060
Why?
Mental Competency
1
2006
51
0.060
Why?
Managed Care Programs
1
2006
61
0.060
Why?
ROC Curve
3
2017
557
0.060
Why?
Hallucinations
2
1995
26
0.060
Why?
Anticholesteremic Agents
1
2008
230
0.060
Why?
Genetic Variation
1
2012
1480
0.060
Why?
Self Disclosure
1
2005
24
0.060
Why?
Monoamine Oxidase Inhibitors
1
2024
12
0.060
Why?
Recovery of Function
1
2007
437
0.060
Why?
Interviews as Topic
2
2003
368
0.060
Why?
Neuroprotective Agents
1
2006
150
0.060
Why?
Area Under Curve
3
2011
313
0.060
Why?
Incidence
5
2010
3048
0.060
Why?
Levodopa
1
2024
90
0.060
Why?
Monoamine Oxidase
1
2024
11
0.060
Why?
Ambulatory Care Facilities
1
2006
229
0.060
Why?
Self Care
1
2006
212
0.060
Why?
Administration, Intravenous
1
2024
143
0.060
Why?
Drug Evaluation, Preclinical
2
2019
151
0.060
Why?
Consensus
2
2022
612
0.060
Why?
Anthropometry
1
2004
197
0.060
Why?
Disease Models, Animal
2
2012
4273
0.060
Why?
Gene Expression Profiling
3
2017
1682
0.060
Why?
Linguistics
2
1993
18
0.050
Why?
Memory, Short-Term
1
2004
140
0.050
Why?
N-Methylaspartate
1
2003
29
0.050
Why?
Reference Values
1
2004
697
0.050
Why?
Neuroimaging
2
2018
332
0.050
Why?
Sampling Studies
1
2003
74
0.050
Why?
Comorbidity
3
2002
1496
0.050
Why?
Patients
1
2024
121
0.050
Why?
Behavioral Symptoms
1
2003
25
0.050
Why?
Carbamates
1
2003
57
0.050
Why?
History, 19th Century
2
1993
117
0.050
Why?
Tremor
1
2024
129
0.050
Why?
Drug Administration Schedule
3
2016
730
0.050
Why?
Task Performance and Analysis
1
2003
95
0.050
Why?
Dopamine Plasma Membrane Transport Proteins
1
2022
34
0.050
Why?
Amyloid
1
2022
65
0.050
Why?
Electrocardiography
1
2008
958
0.050
Why?
Videotape Recording
1
2002
57
0.050
Why?
Alcohol Drinking
1
2004
337
0.050
Why?
Surveys and Questionnaires
5
2017
3670
0.050
Why?
Smoking
2
2004
1031
0.050
Why?
Observational Studies as Topic
1
2022
84
0.050
Why?
Brain Edema
2
2013
69
0.050
Why?
History, 20th Century
2
1993
383
0.050
Why?
Prosopagnosia
1
2001
1
0.050
Why?
Adaptive Clinical Trials as Topic
1
2021
7
0.050
Why?
Socioeconomic Factors
1
2004
866
0.050
Why?
Learning
1
2004
362
0.050
Why?
Metabolic Syndrome
1
2004
330
0.050
Why?
Practice Guidelines as Topic
5
1998
1262
0.040
Why?
Quality of Life
2
2001
1929
0.040
Why?
Estrogens, Conjugated (USP)
1
2000
16
0.040
Why?
Brain Mapping
2
2012
399
0.040
Why?
Atrophy
2
2013
226
0.040
Why?
Estrogen Replacement Therapy
1
2000
44
0.040
Why?
Prognosis
2
2016
4514
0.040
Why?
Neurofilament Proteins
1
2019
28
0.040
Why?
Drug Tolerance
1
1999
40
0.040
Why?
Hypertension
2
2004
1287
0.040
Why?
Age Factors
1
2004
2802
0.040
Why?
Drug Design
2
2009
146
0.040
Why?
Haplotypes
1
2019
519
0.040
Why?
European Union
1
2017
17
0.040
Why?
Protein Interaction Maps
1
2017
76
0.030
Why?
Neurodegenerative Diseases
1
2000
253
0.030
Why?
Synaptic Transmission
1
1999
348
0.030
Why?
Depressive Disorder, Major
1
2002
398
0.030
Why?
Linkage Disequilibrium
1
2017
310
0.030
Why?
Sequence Homology, Amino Acid
1
2017
657
0.030
Why?
Dysarthria
1
1996
21
0.030
Why?
Lipid Metabolism
1
2019
351
0.030
Why?
Temporal Lobe
1
1997
116
0.030
Why?
Spain
1
2016
53
0.030
Why?
Mice, Transgenic
2
2012
2390
0.030
Why?
Perfusion
1
1997
197
0.030
Why?
Gene Frequency
1
2017
713
0.030
Why?
Parietal Lobe
1
1995
42
0.030
Why?
Frontal Lobe
1
1995
111
0.030
Why?
Survival Analysis
2
2009
1472
0.030
Why?
Odds Ratio
1
2017
1243
0.030
Why?
Datasets as Topic
1
2014
85
0.030
Why?
Genetic Heterogeneity
1
2014
123
0.030
Why?
Speech-Language Pathology
1
1993
13
0.030
Why?
Language Disorders
1
1993
24
0.030
Why?
Stroke
2
2016
958
0.030
Why?
Thailand
1
2013
34
0.030
Why?
History, 18th Century
1
1993
69
0.030
Why?
Multivariate Analysis
1
1997
1414
0.030
Why?
Brain Chemistry
1
2013
122
0.030
Why?
Brain Diseases
1
1996
296
0.030
Why?
Speech Disorders
1
1993
42
0.030
Why?
PAX6 Transcription Factor
1
2012
37
0.030
Why?
Amino Acid Sequence
1
2017
2696
0.030
Why?
Paired Box Transcription Factors
1
2012
75
0.030
Why?
Registries
3
2009
1394
0.030
Why?
Genetic Testing
1
2019
997
0.030
Why?
Exome
1
2017
1041
0.030
Why?
Ambulatory Care
1
1995
377
0.030
Why?
Family
1
1995
578
0.020
Why?
Corpus Callosum
1
1992
98
0.020
Why?
Self Report
1
2015
510
0.020
Why?
Aphasia, Broca
1
1991
1
0.020
Why?
Qualitative Research
1
2015
520
0.020
Why?
Emotions
2
2005
359
0.020
Why?
Gene-Environment Interaction
1
2012
120
0.020
Why?
Cerebrospinal Fluid
1
2011
93
0.020
Why?
Authorship
1
2011
29
0.020
Why?
Cytoskeletal Proteins
1
2013
268
0.020
Why?
Decision Making
1
1996
653
0.020
Why?
Eye Proteins
1
2012
217
0.020
Why?
Brain Injuries, Traumatic
1
2016
370
0.020
Why?
Receptors, Odorant
1
2011
36
0.020
Why?
Glycogen Synthase Kinase 3
1
2011
64
0.020
Why?
Chromosomes, Human, Pair 14
1
2011
100
0.020
Why?
Residence Characteristics
1
2013
269
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2014
1012
0.020
Why?
Visual Cortex
1
2012
109
0.020
Why?
Triglycerides
1
2013
562
0.020
Why?
Genetic Association Studies
1
2014
761
0.020
Why?
Community Mental Health Services
1
2010
38
0.020
Why?
Cholinergic Antagonists
1
2010
51
0.020
Why?
Astrocytes
1
2012
251
0.020
Why?
Homeodomain Proteins
1
2012
543
0.020
Why?
Family Relations
1
2010
69
0.020
Why?
Gene Deletion
1
2013
793
0.020
Why?
Social Environment
1
2010
120
0.020
Why?
Anti-Anxiety Agents
1
2010
72
0.020
Why?
Federal Government
1
2009
15
0.020
Why?
Comparative Genomic Hybridization
1
2011
574
0.020
Why?
Nursing Homes
1
2010
95
0.020
Why?
Organ Size
1
2010
412
0.020
Why?
Saccharomyces cerevisiae
1
2012
422
0.020
Why?
Models, Genetic
1
2012
766
0.020
Why?
Synapses
1
2012
448
0.020
Why?
Reference Standards
2
2002
240
0.020
Why?
Phosphorylation
1
2012
1608
0.020
Why?
Down-Regulation
1
2011
697
0.020
Why?
Academies and Institutes
1
2009
84
0.020
Why?
Handwriting
1
2008
8
0.020
Why?
Chromosome Mapping
1
2011
1081
0.020
Why?
Mental Disorders
2
2013
821
0.020
Why?
Interdisciplinary Communication
1
2009
134
0.020
Why?
Models, Biological
1
1993
1441
0.020
Why?
Hospitals, Veterans
1
2010
354
0.020
Why?
Repressor Proteins
1
2012
810
0.020
Why?
Heterozygote
1
2009
672
0.020
Why?
Computational Biology
1
2011
798
0.020
Why?
Pain
1
2010
470
0.020
Why?
Depressive Disorder
1
2010
449
0.020
Why?
Cholesterol, LDL
1
2010
557
0.020
Why?
Hygiene
1
2006
25
0.020
Why?
Logistic Models
1
2010
1793
0.020
Why?
Nerve Tissue Proteins
1
2011
1114
0.020
Why?
Demography
1
2005
239
0.010
Why?
Mice
2
2012
17503
0.010
Why?
Clinical Protocols
1
2005
235
0.010
Why?
Disability Evaluation
1
2005
190
0.010
Why?
Genomics
1
2012
1477
0.010
Why?
Cost-Benefit Analysis
1
2006
501
0.010
Why?
Phenotype
1
2013
4228
0.010
Why?
Behavior
1
2003
75
0.010
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2010
714
0.010
Why?
Patient Education as Topic
1
2006
451
0.010
Why?
Medicare
1
2006
424
0.010
Why?
Hypercholesterolemia
1
2003
226
0.010
Why?
Survival Rate
1
2005
1996
0.010
Why?
Risk Assessment
1
2009
3316
0.010
Why?
Animals
2
2012
33759
0.010
Why?
Neurology
1
2002
108
0.010
Why?
Pregnancy
1
2012
7161
0.010
Why?
Population Surveillance
1
2002
386
0.010
Why?
Heart Diseases
1
2003
482
0.010
Why?
Hysterectomy
1
2000
185
0.010
Why?
Local Government
1
1997
3
0.010
Why?
Retirement
1
1997
18
0.010
Why?
Epidemiologic Methods
1
1997
111
0.010
Why?
Adolescent
1
2012
19110
0.010
Why?
Wechsler Scales
1
1992
21
0.010
Why?
Writing
1
1992
59
0.010
Why?
Tomography, X-Ray Computed
1
1991
2058
0.000
Why?
DOODY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (472)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_